{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:42:23Z","timestamp":1791549743132,"version":"4.3.4"},"reference-count":157,"publisher":"The Endocrine Society","issue":"6","funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["DEQ20140329556"],"award-info":[{"award-number":["DEQ20140329556"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12,1]]},"DOI":"10.1210\/er.2017-00189","type":"journal-article","created":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T14:07:17Z","timestamp":1501682837000},"page":"516-537","source":"Crossref","is-referenced-by-count":95,"title":["Genetic Causes of Functional Adrenocortical Adenomas"],"prefix":"10.1210","volume":"38","author":[{"given":"Maria-Christina","family":"Zennaro","sequence":"first","affiliation":[{"name":"French National Institute of Health and Medical Research (INSERM), Unit\u00e9 Mixte de Recherche Scientifique (UMRS)_970, Paris Cardiovascular Research Center, France"},{"name":"Universit\u00e9 Paris Descartes, Sorbonne Paris Cit\u00e9, France"},{"name":"Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Europ\u00e9en Georges Pompidou, Service de G\u00e9n\u00e9tique, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheerazed","family":"Boulkroun","sequence":"additional","affiliation":[{"name":"French National Institute of Health and Medical Research (INSERM), Unit\u00e9 Mixte de Recherche Scientifique (UMRS)_970, Paris Cardiovascular Research Center, France"},{"name":"Universit\u00e9 Paris Descartes, Sorbonne Paris Cit\u00e9, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Fernandes-Rosa","sequence":"additional","affiliation":[{"name":"French National Institute of Health and Medical Research (INSERM), Unit\u00e9 Mixte de Recherche Scientifique (UMRS)_970, Paris Cardiovascular Research Center, France"},{"name":"Universit\u00e9 Paris Descartes, Sorbonne Paris Cit\u00e9, France"},{"name":"Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Europ\u00e9en Georges Pompidou, Service de G\u00e9n\u00e9tique, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2017,8,2]]},"reference":[{"issue":"4","key":"2019041122213497700_B1","first-page":"460","article-title":"Incidentally discovered adrenal masses","volume":"16","author":"Kloos","year":"1995","journal-title":"Endocr Rev"},{"issue":"1","key":"2019041122213497700_B2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1677\/JOE-08-0353","article-title":"Role of DNA methylation in the tissue-specific expression of the CYP17A1 gene for steroidogenesis in rodents","volume":"202","author":"Missaghian","year":"2009","journal-title":"J Endocrinol"},{"issue":"6357","key":"2019041122213497700_B3","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","article-title":"A chimaeric 11 beta-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension","volume":"355","author":"Lifton","year":"1992","journal-title":"Nature"},{"issue":"9","key":"2019041122213497700_B4","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/00004872-200018090-00002","article-title":"Primary aldosteronism: learning from the study of familial varieties","volume":"18","author":"Stowasser","year":"2000","journal-title":"J Hypertens"},{"issue":"22","key":"2019041122213497700_B5","first-page":"1109","article-title":"Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone","volume":"95","author":"Sutherland","year":"1966","journal-title":"Can Med Assoc J"},{"issue":"4","key":"2019041122213497700_B6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1210\/edrv-1-4-421","article-title":"Hypertension of childhood with suppressed renin","volume":"1","author":"New","year":"1980","journal-title":"Endocr Rev"},{"issue":"1","key":"2019041122213497700_B7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.1.06017","article-title":"The new biology of aldosterone","volume":"186","author":"Connell","year":"2005","journal-title":"J Endocrinol"},{"issue":"6","key":"2019041122213497700_B8","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1055\/s-0029-1243601","article-title":"TASK1 and TASK3 potassium channels: determinants of aldosterone secretion and adrenocortical zonation","volume":"42","author":"Bandulik","year":"2010","journal-title":"Horm Metab Res"},{"issue":"2","key":"2019041122213497700_B9","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1152\/physrev.00030.2003","article-title":"Control of aldosterone secretion: a model for convergence in cellular signaling pathways","volume":"84","author":"Sp\u00e4t","year":"2004","journal-title":"Physiol Rev"},{"issue":"1-2","key":"2019041122213497700_B10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mce.2003.10.011","article-title":"The regulation of aldosterone synthase expression","volume":"217","author":"Bassett","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"2019041122213497700_B11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fendo.2016.00024","article-title":"Impact of ACTH signaling on transcriptional regulation of steroidogenic genes","volume":"7","author":"Ruggiero","year":"2016","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2019041122213497700_B12","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fnins.2016.00238","article-title":"Functional zonation of the adult mammalian adrenal cortex","volume":"10","author":"Vinson","year":"2016","journal-title":"Front Neurosci"},{"key":"2019041122213497700_B13","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.mce.2014.11.013","article-title":"Paracrine control of steroidogenesis by serotonin in adrenocortical neoplasms","volume":"408","author":"Lefebvre","year":"2015","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"2019041122213497700_B14","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041122213497700_B15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-0031-1295438","article-title":"Prevalence of primary aldosteronism in patient\u2019s cohorts and in population-based studies\u2014a review of the current literature","volume":"44","author":"Hannemann","year":"2012","journal-title":"Horm Metab Res"},{"issue":"11","key":"2019041122213497700_B16","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2019041122213497700_B17","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"issue":"2","key":"2019041122213497700_B18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","article-title":"Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study","volume":"62","author":"Savard","year":"2013","journal-title":"Hypertension"},{"issue":"12","key":"2019041122213497700_B19","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2013-2805","article-title":"Long-term cardio- and cerebrovascular events in patients with primary aldosteronism","volume":"98","author":"Mulatero","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041122213497700_B20","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","article-title":"Renal damage in primary aldosteronism: results of the PAPY study","volume":"48","author":"Rossi","year":"2006","journal-title":"Hypertension"},{"issue":"6","key":"2019041122213497700_B21","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1161\/01.CIR.95.6.1471","article-title":"Remodeling of the left ventricle in primary aldosteronism due to Conn\u2019s adenoma","volume":"95","author":"Rossi","year":"1997","journal-title":"Circulation"},{"issue":"6","key":"2019041122213497700_B22","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/CIRCIMAGING.112.974576","article-title":"Demonstration of blood pressure-independent noninfarct myocardial fibrosis in primary aldosteronism: a cardiac magnetic resonance imaging study","volume":"5","author":"Freel","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"issue":"3","key":"2019041122213497700_B23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ando.2016.05.001","article-title":"SFE\/SFHTA\/AFCE primary aldosteronism consensus: introduction and handbook","volume":"77","author":"Amar","year":"2016","journal-title":"Ann Endocrinol (Paris)"},{"issue":"6018","key":"2019041122213497700_B24","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"issue":"9","key":"2019041122213497700_B25","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ng.2716","article-title":"Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension","volume":"45","author":"Azizan","year":"2013","journal-title":"Nat Genet"},{"issue":"9","key":"2019041122213497700_B26","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/ng.2695","article-title":"Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism","volume":"45","author":"Scholl","year":"2013","journal-title":"Nat Genet"},{"key":"2019041122213497700_B27","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ng.2550","article-title":"Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension","volume":"45","author":"Beuschlein","year":"2013","journal-title":"Nat Genet"},{"issue":"6","key":"2019041122213497700_B28","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/cen.12873","article-title":"Novel somatic mutations in primary hyperaldosteronism are related to the clinical, radiological and pathological phenotype","volume":"83","author":"Scholl","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041122213497700_B29","doi-asserted-by":"crossref","first-page":"19546","DOI":"10.1038\/srep19546","article-title":"Activating mutations in CTNNB1 in aldosterone producing adenomas","volume":"6","author":"\u00c5kerstr\u00f6m","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"2019041122213497700_B30","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/HYPERTENSIONAHA.114.03419","article-title":"Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma","volume":"64","author":"Fernandes-Rosa","year":"2014","journal-title":"Hypertension"},{"issue":"1","key":"2019041122213497700_B31","doi-asserted-by":"crossref","first-page":"E155","DOI":"10.1210\/jc.2014-3009","article-title":"Novel KCNJ5 mutations in sporadic aldosterone-producing adenoma reduce Kir3.4 membrane abundance","volume":"100","author":"Cheng","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019041122213497700_B32","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1210\/jc.2011-2885","article-title":"Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas","volume":"97","author":"Taguchi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041122213497700_B33","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/HYPERTENSIONAHA.114.03346","article-title":"Clinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma","volume":"65","author":"Zheng","year":"2015","journal-title":"Hypertension"},{"issue":"16","key":"2019041122213497700_B34","doi-asserted-by":"crossref","first-page":"e708","DOI":"10.1097\/MD.0000000000000708","article-title":"Prevalence and characterization of somatic mutations in Chinese aldosterone-producing adenoma patients","volume":"94","author":"Wang","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"2019041122213497700_B35","doi-asserted-by":"crossref","first-page":"11396","DOI":"10.1038\/srep11396","article-title":"Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population","volume":"5","author":"Wu","year":"2015","journal-title":"Sci Rep"},{"issue":"2","key":"2019041122213497700_B36","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1210\/jc.2015-3284","article-title":"Clinical and steroidogenic characteristics of aldosterone-producing adenomas with ATPase or CACNA1D gene mutations","volume":"101","author":"Kitamoto","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019041122213497700_B37","doi-asserted-by":"crossref","first-page":"e0147590","DOI":"10.1371\/journal.pone.0147590","article-title":"Genetics of aldosterone-producing adenoma in Korean patients","volume":"11","author":"Hong","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"2019041122213497700_B38","doi-asserted-by":"crossref","first-page":"E2307","DOI":"10.1210\/jc.2012-2342","article-title":"Somatic mutations in the KCNJ5 gene raise the lateralization index: implications for the diagnosis of primary aldosteronism by adrenal vein sampling","volume":"97","author":"Seccia","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019041122213497700_B39","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1530\/EJE-13-0551","article-title":"Lack of influence of somatic mutations on steroid gradients during adrenal vein sampling in aldosterone-producing adenoma patients","volume":"169","author":"O\u00dfwald","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2019041122213497700_B40","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1530\/ERC-15-0321","article-title":"Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas","volume":"22","author":"\u00c5kerstr\u00f6m","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"2019041122213497700_B41","doi-asserted-by":"crossref","first-page":"39121","DOI":"10.1038\/srep39121","article-title":"The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes","volume":"7","author":"Wu","year":"2017","journal-title":"Sci Rep"},{"issue":"3","key":"2019041122213497700_B42","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/HYPERTENSIONAHA.111.186478","article-title":"Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism","volume":"59","author":"Boulkroun","year":"2012","journal-title":"Hypertension"},{"issue":"1-2","key":"2019041122213497700_B43","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.mce.2013.01.018","article-title":"KCNJ5 mutations in aldosterone producing adenoma and relationship with adrenal cortex remodeling","volume":"371","author":"Boulkroun","year":"2013","journal-title":"Mol Cell Endocrinol"},{"issue":"7","key":"2019041122213497700_B44","doi-asserted-by":"crossref","first-page":"e41926","DOI":"10.1371\/journal.pone.0041926","article-title":"Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter","volume":"7","author":"\u00c5kerstr\u00f6m","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"2019041122213497700_B45","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/HYPERTENSIONAHA.111.186239","article-title":"Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas","volume":"59","author":"Azizan","year":"2012","journal-title":"Hypertension"},{"issue":"5","key":"2019041122213497700_B46","doi-asserted-by":"crossref","first-page":"E819","DOI":"10.1210\/jc.2011-2965","article-title":"Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors","volume":"97","author":"Azizan","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019041122213497700_B47","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/HYPERTENSIONAHA.113.01733","article-title":"Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas","volume":"63","author":"Williams","year":"2014","journal-title":"Hypertension"},{"issue":"2","key":"2019041122213497700_B48","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5551\/jat.24455","article-title":"Comparison of cardiovascular complications in patients with and without KCNJ5 gene mutations harboring aldosterone-producing adenomas","volume":"22","author":"Kitamoto","year":"2015","journal-title":"J Atheroscler Thromb"},{"issue":"9","key":"2019041122213497700_B49","doi-asserted-by":"crossref","first-page":"E1765","DOI":"10.1210\/jc.2014-1927","article-title":"A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium","volume":"99","author":"Kuppusamy","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122213497700_B50","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.mce.2015.04.022","article-title":"Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas","volume":"411","author":"Monticone","year":"2015","journal-title":"Mol Cell Endocrinol"},{"issue":"8","key":"2019041122213497700_B51","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1210\/jc.2016-1700","article-title":"PRKACA somatic mutations are rare findings in aldosterone-producing adenomas","volume":"101","author":"Rhayem","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041122213497700_B52","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/HYPERTENSIONAHA.111.183996","article-title":"KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism","volume":"59","author":"Mulatero","year":"2012","journal-title":"Hypertension"},{"issue":"3","key":"2019041122213497700_B53","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1210\/jc.2015-3239","article-title":"Molecular heterogeneity in aldosterone-producing adenomas","volume":"101","author":"Nanba","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2019041122213497700_B54","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1097\/HJH.0b013e328356139f","article-title":"Characterization of a novel somatic KCNJ5 mutation delI157 in an aldosterone-producing adenoma","volume":"30","author":"Murthy","year":"2012","journal-title":"J Hypertens"},{"issue":"11","key":"2019041122213497700_B55","doi-asserted-by":"crossref","first-page":"E1861","DOI":"10.1210\/jc.2013-2428","article-title":"A novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III","volume":"98","author":"Monticone","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2019041122213497700_B56","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1210\/me.2015-1195","article-title":"Novel insertion mutation in KCNJ5 channel produces constitutive aldosterone release from H295R cells","volume":"29","author":"Hardege","year":"2015","journal-title":"Mol Endocrinol"},{"issue":"1","key":"2019041122213497700_B57","doi-asserted-by":"crossref","first-page":"L1","DOI":"10.1530\/ERC-13-0466","article-title":"Complementary somatic mutations of KCNJ5, ATP1A1, and ATP2B3 in sporadic aldosterone producing adrenal adenomas","volume":"21","author":"Dutta","year":"2014","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"2019041122213497700_B58","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1210\/en.2011-1733","article-title":"Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis","volume":"153","author":"Oki","year":"2012","journal-title":"Endocrinology"},{"issue":"7","key":"2019041122213497700_B59","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1073\/pnas.1121407109","article-title":"Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5","volume":"109","author":"Scholl","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"2019041122213497700_B60","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1210\/en.2015-1466","article-title":"Pathogenesis of adrenal aldosterone-producing adenomas carrying mutations of the Na(+)\/K(+)-ATPase","volume":"156","author":"Stindl","year":"2015","journal-title":"Endocrinology"},{"issue":"6","key":"2019041122213497700_B61","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1210\/en.2015-2029","article-title":"Cellular pathophysiology of an adrenal adenoma-associated mutant of the plasma membrane Ca(2+)-ATPase ATP2B3","volume":"157","author":"Tauber","year":"2016","journal-title":"Endocrinology"},{"issue":"2","key":"2019041122213497700_B62","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.neulet.2010.08.085","article-title":"Signaling complexes of voltage-gated sodium and calcium channels","volume":"486","author":"Catterall","year":"2010","journal-title":"Neurosci Lett"},{"issue":"10","key":"2019041122213497700_B63","doi-asserted-by":"crossref","first-page":"R437","DOI":"10.1530\/ERC-16-0055","article-title":"Genetics of primary hyperaldosteronism","volume":"23","author":"Dutta","year":"2016","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"2019041122213497700_B64","doi-asserted-by":"crossref","first-page":"E1089","DOI":"10.1210\/jc.2015-2149","article-title":"A meta-analysis of somatic KCNJ5 K(+) channel mutations in 1636 patients with an aldosterone-producing adenoma","volume":"100","author":"Lenzini","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"15","key":"2019041122213497700_B65","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJMoa1504869","article-title":"Pregnancy, primary aldosteronism, and adrenal CTNNB1 mutations","volume":"373","author":"Teo","year":"2015","journal-title":"N Engl J Med"},{"key":"2019041122213497700_B66","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ebiom.2016.10.002","article-title":"CACNA1H mutations are associated with different forms of primary aldosteronism","volume":"13","author":"Daniil","year":"2016","journal-title":"EBioMedicine"},{"issue":"4","key":"2019041122213497700_B67","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1161\/HYPERTENSIONAHA.113.02234","article-title":"Role for germline mutations and a rare coding single nucleotide polymorphism within the KCNJ5 potassium channel in a large cohort of sporadic cases of primary aldosteronism","volume":"63","author":"Murthy","year":"2014","journal-title":"Hypertension"},{"issue":"6","key":"2019041122213497700_B68","doi-asserted-by":"crossref","first-page":"E900","DOI":"10.1210\/jc.2014-4167","article-title":"Primary aldosteronism and ARMC5 variants","volume":"100","author":"Zilbermint","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019041122213497700_B69","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1172\/JCI61996","article-title":"Zona glomerulosa cells of the mouse adrenal cortex are intrinsic electrical oscillators","volume":"122","author":"Hu","year":"2012","journal-title":"J Clin Invest"},{"key":"2019041122213497700_B70","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1749-6632.2002.tb04414.x","article-title":"New genetic insights in familial hyperaldosteronism","volume":"970","author":"Jackson","year":"2002","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"2019041122213497700_B71","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/sj.jhh.1001821","article-title":"Glucocorticoid remediable aldosteronism (GRA) screening in hypertensive patients from a primary care setting","volume":"19","author":"Pizzolo","year":"2005","journal-title":"J Hum Hypertens"},{"issue":"5","key":"2019041122213497700_B72","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1161\/HYPERTENSIONAHA.111.175083","article-title":"Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms)","volume":"58","author":"Mulatero","year":"2011","journal-title":"Hypertension"},{"issue":"6","key":"2019041122213497700_B73","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1161\/HYPERTENSIONAHA.110.168740","article-title":"Frequency of familial hyperaldosteronism type 1 in a hypertensive pediatric population: clinical and biochemical presentation","volume":"57","author":"Aglony","year":"2011","journal-title":"Hypertension"},{"issue":"2","key":"2019041122213497700_B74","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nrendo.2012.230","article-title":"Role of KCNJ5 in familial and sporadic primary aldosteronism","volume":"9","author":"Mulatero","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"2019041122213497700_B75","doi-asserted-by":"crossref","first-page":"e06315","DOI":"10.7554\/eLife.06315","article-title":"Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism","volume":"4","author":"Scholl","year":"2015","journal-title":"eLife"},{"issue":"2","key":"2019041122213497700_B76","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000358197","article-title":"Discordant genotype-phenotype correlation in familial hyperaldosteronism type III with KCNJ5 gene mutation: a patient report and review of the literature","volume":"82","author":"Adachi","year":"2014","journal-title":"Horm Res Paediatr"},{"issue":"5","key":"2019041122213497700_B77","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/HYPERTENSIONAHA.110.158543","article-title":"Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism","volume":"56","author":"Boulkroun","year":"2010","journal-title":"Hypertension"},{"issue":"4","key":"2019041122213497700_B78","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0300-595X(85)80078-5","article-title":"Histopathology of the human adrenal cortex","volume":"14","author":"Neville","year":"1985","journal-title":"Clin Endocrinol Metab"},{"issue":"4","key":"2019041122213497700_B79","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1210\/jc.2014-1062","article-title":"Channels and pumps in aldosterone-producing adenomas","volume":"99","author":"Gomez-Sanchez","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2019041122213497700_B80","doi-asserted-by":"crossref","first-page":"E1341","DOI":"10.1210\/jc.2013-4255","article-title":"Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit","volume":"99","author":"Dekkers","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019041122213497700_B81","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1161\/HYPERTENSIONAHA.115.05993","article-title":"Different somatic mutations in multinodular adrenals with aldosterone-producing adenoma","volume":"66","author":"Fernandes-Rosa","year":"2015","journal-title":"Hypertension"},{"issue":"11","key":"2019041122213497700_B82","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1210\/jc.2016-1874","article-title":"Aldosterone-producing adenoma with a somatic KCNJ5 mutation revealing APC-dependent familial adenomatous polyposis","volume":"101","author":"Vouillarmet","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019041122213497700_B83","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1210\/jc.2015-3285","article-title":"Case report: nodule development from subcapsular aldosterone-producing cell clusters causes hyperaldosteronism","volume":"101","author":"Nishimoto","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019041122213497700_B84","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1210\/jc.2009-2010","article-title":"Adrenocortical zonation in humans under normal and pathological conditions","volume":"95","author":"Nishimoto","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2019041122213497700_B85","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1210\/en.2011-1205","article-title":"Aldosterone-producing adenoma formation in the adrenal cortex involves expression of stem\/progenitor cell markers","volume":"152","author":"Boulkroun","year":"2011","journal-title":"Endocrinology"},{"issue":"33","key":"2019041122213497700_B86","doi-asserted-by":"crossref","first-page":"E4591","DOI":"10.1073\/pnas.1505529112","article-title":"Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands","volume":"112","author":"Nishimoto","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2019041122213497700_B87","first-page":"1189","article-title":"Histopathological classification of cross-sectional image negative hyperaldosteronism","volume":"102","author":"Yamazaki","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2019041122213497700_B88","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1310359","article-title":"Constitutive activation of PKA catalytic subunit in adrenal Cushing\u2019s syndrome","volume":"370","author":"Beuschlein","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"2019041122213497700_B89","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/ng.2956","article-title":"Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors","volume":"46","author":"Goh","year":"2014","journal-title":"Nat Genet"},{"issue":"6186","key":"2019041122213497700_B90","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1126\/science.1249480","article-title":"Activating hotspot L205R mutation in PRKACA and adrenal Cushing\u2019s syndrome","volume":"344","author":"Cao","year":"2014","journal-title":"Science"},{"issue":"6186","key":"2019041122213497700_B91","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1126\/science.1252328","article-title":"Recurrent somatic mutations underlie corticotropin-independent Cushing\u2019s syndrome","volume":"344","author":"Sato","year":"2014","journal-title":"Science"},{"issue":"6","key":"2019041122213497700_B92","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1530\/EJE-14-1113","article-title":"PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases","volume":"172","author":"Thiel","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2019041122213497700_B93","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1507\/endocrj.EJ15-0642","article-title":"GNAS mutations in adrenal aldosterone-producing adenomas","volume":"63","author":"Nakajima","year":"2016","journal-title":"Endocr J"},{"issue":"10","key":"2019041122213497700_B94","doi-asserted-by":"crossref","first-page":"E2093","DOI":"10.1210\/jc.2014-2152","article-title":"Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing\u2019s syndrome: a European multicentric study","volume":"99","author":"Di Dalmazi","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019041122213497700_B95","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1507\/endocrj.EJ16-0243","article-title":"Characteristics of Japanese aldosterone-producing adenomas with KCNJ5 mutations","volume":"64","author":"Okamura","year":"2017","journal-title":"Endocr J"},{"issue":"8","key":"2019041122213497700_B96","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1507\/endocrj.EJ14-0282","article-title":"Somatic mutations of the catalytic subunit of cyclic AMP-dependent protein kinase (PRKACA) gene in Japanese patients with several adrenal adenomas secreting cortisol [rapid communication]","volume":"61","author":"Nakajima","year":"2014","journal-title":"Endocr J"},{"issue":"9","key":"2019041122213497700_B97","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1210\/jc.2016-1586","article-title":"Genetic landscape of sporadic unilateral adrenocortical adenomas without PRKACA p.Leu206Arg mutation","volume":"101","author":"Ronchi","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2019041122213497700_B98","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1210\/jc.2010-2743","article-title":"Cardiovascular complications of patients with aldosteronism associated with autonomous cortisol secretion","volume":"96","author":"Nakajima","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041122213497700_B99","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MED.0000000000000248","article-title":"Immunohistochemistry of the adrenal in primary aldosteronism","volume":"23","author":"Gomez-Sanchez","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"8","key":"2019041122213497700_B100","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1507\/endocrj.EJ12-0247","article-title":"KCNJ5 mutations in aldosterone- and cortisol-co-secreting adrenal adenomas","volume":"59","author":"Yamada","year":"2012","journal-title":"Endocr J"},{"issue":"9","key":"2019041122213497700_B101","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1097\/HJH.0b013e32834937f3","article-title":"Concurrent primary aldosteronism and subclinical cortisol hypersecretion: a prospective study","volume":"29","author":"Fallo","year":"2011","journal-title":"J Hypertens"},{"issue":"2","key":"2019041122213497700_B102","doi-asserted-by":"crossref","first-page":"K1","DOI":"10.1530\/EJE-16-0262","article-title":"Double adrenocortical adenomas harboring independent KCNJ5 and PRKACA somatic mutations","volume":"175","author":"Nanba","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2019041122213497700_B103","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1210\/en.2002-220275","article-title":"Wnt-4 deficiency alters mouse adrenal cortex function, reducing aldosterone production","volume":"143","author":"Heikkil\u00e4","year":"2002","journal-title":"Endocrinology"},{"issue":"1","key":"2019041122213497700_B104","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ajhg.2007.08.005","article-title":"SERKAL syndrome: an autosomal-recessive disorder caused by a loss-of-function mutation in WNT4","volume":"82","author":"Mandel","year":"2008","journal-title":"Am J Hum Genet"},{"issue":"9","key":"2019041122213497700_B105","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/dvg.20231","article-title":"Development of a steroidogenic factor 1\/Cre transgenic mouse line","volume":"44","author":"Bingham","year":"2006","journal-title":"Genesis"},{"issue":"15","key":"2019041122213497700_B106","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1242\/dev.021493","article-title":"Targeted disruption of beta-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex","volume":"135","author":"Kim","year":"2008","journal-title":"Development"},{"issue":"13","key":"2019041122213497700_B107","doi-asserted-by":"crossref","first-page":"11421","DOI":"10.18632\/oncotarget.3222","article-title":"Loss of \u03b2-catenin in adrenocortical cancer cells causes growth inhibition and reversal of epithelial-to-mesenchymal transition","volume":"6","author":"Salomon","year":"2015","journal-title":"Oncotarget"},{"issue":"4940","key":"2019041122213497700_B108","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1126\/science.2296722","article-title":"A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse","volume":"247","author":"Moser","year":"1990","journal-title":"Science"},{"issue":"3","key":"2019041122213497700_B109","doi-asserted-by":"crossref","first-page":"R571","DOI":"10.1152\/ajpregu.00070.2009","article-title":"Hyperaldosteronism, hypervolemia, and increased blood pressure in mice expressing defective APC","volume":"297","author":"Bhandaru","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"8","key":"2019041122213497700_B110","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/hmg\/ddq029","article-title":"Constitutive beta-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development","volume":"19","author":"Berthon","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"17","key":"2019041122213497700_B111","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1158\/0008-5472.CAN-05-0593","article-title":"Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors","volume":"65","author":"Tissier","year":"2005","journal-title":"Cancer Res"},{"issue":"2","key":"2019041122213497700_B112","doi-asserted-by":"crossref","first-page":"E419","DOI":"10.1210\/jc.2010-1885","article-title":"Wnt\/\u03b2-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors","volume":"96","author":"Bonnet","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019041122213497700_B113","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/hmg\/ddt484","article-title":"WNT\/\u03b2-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production","volume":"23","author":"Berthon","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"15","key":"2019041122213497700_B114","first-page":"1493","article-title":"Pregnancy, primary aldosteronism, and somatic CTNNB1 mutations","volume":"374","author":"Berthon","year":"2016","journal-title":"N Engl J Med"},{"issue":"15","key":"2019041122213497700_B115","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1056\/NEJMc1514508","article-title":"Pregnancy, primary aldosteronism, and somatic CTNNB1 mutations","volume":"374","author":"Murtha","year":"2016","journal-title":"N Engl J Med"},{"key":"2019041122213497700_B116","doi-asserted-by":"crossref","first-page":"12751","DOI":"10.1038\/ncomms12751","article-title":"PKA inhibits WNT signalling in adrenal cortex zonation and prevents malignant tumour development","volume":"7","author":"Drelon","year":"2016","journal-title":"Nat Commun"},{"issue":"3","key":"2019041122213497700_B117","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/MED.0000000000000061","article-title":"Primary bilateral macronodular adrenal hyperplasia","volume":"21","author":"De Venanzi","year":"2014","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"5","key":"2019041122213497700_B118","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1530\/EJE-13-0308","article-title":"Autocrine\/paracrine regulatory mechanisms in adrenocortical neoplasms responsible for primary adrenal hypercorticism","volume":"169","author":"Lefebvre","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2019041122213497700_B119","doi-asserted-by":"crossref","first-page":"E1501","DOI":"10.1210\/jc.2013-4237","article-title":"ARMC5 mutations are a frequent cause of primary macronodular adrenal hyperplasia","volume":"99","author":"Alencar","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019041122213497700_B120","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1530\/JOE-14-0568","article-title":"Genetics of primary macronodular adrenal hyperplasia","volume":"224","author":"Fragoso","year":"2015","journal-title":"J Endocrinol"},{"issue":"2","key":"2019041122213497700_B121","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.beem.2008.10.011","article-title":"ACTH-independent macronodular adrenal hyperplasia","volume":"23","author":"Lacroix","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"4","key":"2019041122213497700_B122","doi-asserted-by":"crossref","first-page":"M121","DOI":"10.1530\/EJE-15-0532","article-title":"Genetics of primary bilateral macronodular adrenal hyperplasia: a model for early diagnosis of Cushing\u2019s syndrome","volume":"173","author":"Drougat","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"2019041122213497700_B123","doi-asserted-by":"crossref","first-page":"628","DOI":"10.2169\/internalmedicine.36.628","article-title":"Preclinical Cushing\u2019s syndrome due to adrenocorticotropin-independent bilateral adrenocortical macronodular hyperplasia with concurrent excess of gluco- and mineralocorticoids","volume":"36","author":"Yamada","year":"1997","journal-title":"Intern Med"},{"issue":"4","key":"2019041122213497700_B124","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1507\/endocrj.45.485","article-title":"A case of Cushing\u2019s syndrome due to ACTH-independent bilateral macronodular hyperplasia associated with excessive secretion of mineralocorticoids","volume":"45","author":"Hayashi","year":"1998","journal-title":"Endocr J"},{"issue":"1","key":"2019041122213497700_B125","first-page":"75","article-title":"Ectopic and abnormal hormone receptors in adrenal Cushing\u2019s syndrome","volume":"22","author":"Lacroix","year":"2001","journal-title":"Endocr Rev"},{"issue":"11","key":"2019041122213497700_B126","first-page":"5534","article-title":"Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing\u2019s syndrome","volume":"86","author":"Bourdeau","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"22","key":"2019041122213497700_B127","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMoa1304603","article-title":"ARMC5 mutations in macronodular adrenal hyperplasia with Cushing\u2019s syndrome","volume":"369","author":"Assi\u00e9","year":"2013","journal-title":"N Engl J Med"},{"issue":"4","key":"2019041122213497700_B128","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1530\/EJE-15-0205","article-title":"The ARMC5 gene shows extensive genetic variance in primary macronodular adrenocortical hyperplasia","volume":"173","author":"Correa","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"2019041122213497700_B129","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3389\/fendo.2015.00096","article-title":"Novel insights into the genetics and pathophysiology of adrenocortical tumors","volume":"6","author":"Drougat","year":"2015","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2019041122213497700_B130","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.mce.2016.08.018","article-title":"Analysis of ARMC5 expression in human tissues","volume":"441","author":"Berthon","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"2019041122213497700_B131","doi-asserted-by":"crossref","first-page":"13834","DOI":"10.1038\/ncomms13834","article-title":"Armc5 deletion causes developmental defects and compromises T-cell immune responses","volume":"8","author":"Hu","year":"2017","journal-title":"Nat Commun"},{"issue":"6","key":"2019041122213497700_B132","doi-asserted-by":"crossref","first-page":"E1113","DOI":"10.1210\/jc.2013-4280","article-title":"Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation","volume":"99","author":"Faucz","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019041122213497700_B133","doi-asserted-by":"crossref","first-page":"E926","DOI":"10.1210\/jc.2014-4204","article-title":"ARMC5 mutations in a large cohort of primary macronodular adrenal hyperplasia: clinical and functional consequences","volume":"100","author":"Espiard","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041122213497700_B134","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s12020-016-0956-z","article-title":"A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype","volume":"55","author":"Albiger","year":"2017","journal-title":"Endocrine"},{"issue":"9","key":"2019041122213497700_B135","doi-asserted-by":"crossref","first-page":"E1784","DOI":"10.1210\/jc.2014-1265","article-title":"ARMC5 mutations are common in familial bilateral macronodular adrenal hyperplasia","volume":"99","author":"Gagliardi","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019041122213497700_B136","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.1210\/jc.2014-2648","article-title":"Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma","volume":"100","author":"Elbelt","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019041122213497700_B137","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1530\/EJE-15-0642","article-title":"ARMC5 mutations in a large French-Canadian family with cortisol-secreting \u03b2-adrenergic\/vasopressin responsive bilateral macronodular adrenal hyperplasia","volume":"174","author":"Bourdeau","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2019041122213497700_B138","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/jhh.2015.98","article-title":"ARMC5 mutation analysis in patients with primary aldosteronism and bilateral adrenal lesions","volume":"30","author":"Mulatero","year":"2016","journal-title":"J Hum Hypertens"},{"key":"2019041122213497700_B139","first-page":"95","article-title":"The genetic basis of familial adenomatous polyposis and its implications for clinical practice and risk management","volume":"8","author":"Leoz","year":"2015","journal-title":"Appl Clin Genet"},{"issue":"12","key":"2019041122213497700_B140","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/BF02236860","article-title":"Adrenal masses are associated with familial adenomatous polyposis","volume":"43","author":"Smith","year":"2000","journal-title":"Dis Colon Rectum"},{"issue":"21","key":"2019041122213497700_B141","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1158\/1078-0432.CCR-10-1497","article-title":"Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers","volume":"16","author":"Gaujoux","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"8","key":"2019041122213497700_B142","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1210\/jc.2009-0516","article-title":"Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors","volume":"94","author":"Hsiao","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019041122213497700_B143","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7326\/0003-4819-129-6-199809150-00011","article-title":"Multiple endocrine neoplasia type 1: clinical and genetic topics","volume":"129","author":"Marx","year":"1998","journal-title":"Ann Intern Med"},{"issue":"9","key":"2019041122213497700_B144","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.tem.2006.09.004","article-title":"Menin and its interacting proteins: elucidation of menin function","volume":"17","author":"Balogh","year":"2006","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"2019041122213497700_B145","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/EJE-11-0679","article-title":"Adrenal involvement in MEN1: analysis of 715 cases from the Groupe d\u2019etude des Tumeurs Endocrines database","volume":"166","author":"Gatta-Cherifi","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2019041122213497700_B146","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/gcc.2870120114","article-title":"Allelic losses on chromosome band 11q13 in aldosterone-producing adrenal tumors","volume":"12","author":"Iida","year":"1995","journal-title":"Genes Chromosomes Cancer"},{"issue":"6","key":"2019041122213497700_B147","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1210\/jc.2004-2377","article-title":"Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical Cushing syndrome: a clinical and molecular genetic investigation","volume":"90","author":"Matyakhina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041122213497700_B148","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.juro.2012.07.139","article-title":"Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancer","volume":"189","author":"Shuch","year":"2013","journal-title":"J Urol"},{"issue":"4","key":"2019041122213497700_B149","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1210\/jc.2009-2321","article-title":"Cushing syndrome in the McCune-Albright syndrome","volume":"95","author":"Brown","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019041122213497700_B150","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1210\/jc.2002-021362","article-title":"Cushing\u2019s syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene","volume":"88","author":"Fragoso","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122213497700_B151","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1158\/1078-0432.CCR-08-0106","article-title":"Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors","volume":"14","author":"Libe","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"11","key":"2019041122213497700_B152","doi-asserted-by":"crossref","first-page":"E2063","DOI":"10.1210\/jc.2012-2275","article-title":"Phosphodiesterase 11A (PDE11A) gene defects in patients with ACTH-independent macronodular adrenal hyperplasia (AIMAH): functional variants may contribute to genetic susceptibility of bilateral adrenal tumors","volume":"97","author":"Vezzosi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2019041122213497700_B153","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1210\/me.2002-0099","article-title":"Impaired desensitization of a mutant adrenocorticotropin receptor associated with apparent constitutive activity","volume":"16","author":"Swords","year":"2002","journal-title":"Mol Endocrinol"},{"issue":"1","key":"2019041122213497700_B154","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.humpath.2014.09.005","article-title":"Germline PRKACA amplification leads to Cushing syndrome caused by 3 adrenocortical pathologic phenotypes","volume":"46","author":"Carney","year":"2015","journal-title":"Hum Pathol"},{"issue":"4","key":"2019041122213497700_B155","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1210\/en.2013-1944","article-title":"Pharmacology and pathophysiology of mutated KCNJ5 found in adrenal aldosterone-producing adenomas","volume":"155","author":"Tauber","year":"2014","journal-title":"Endocrinology"},{"issue":"7","key":"2019041122213497700_B156","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1172\/JCI91733","article-title":"Macrolides selectively inhibit mutant KCNJ5 potassium channels that cause aldosterone-producing adenoma","volume":"127","author":"Scholl","year":"2017","journal-title":"J Clin Invest"},{"key":"2019041122213497700_B157","first-page":"e93136","article-title":"Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism","volume-title":"JCI Insight","author":"Arlt","year":"2017"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/38\/6\/516\/22189082\/er.2017-00189.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T12:45:59Z","timestamp":1555073159000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/38\/6\/516\/4058049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,2]]},"references-count":157,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,8,2]]},"published-print":{"date-parts":[[2017,12,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2017-00189","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,12,1]]},"published":{"date-parts":[[2017,8,2]]}}}